Opportunities and challenges for anti-CD47 antibodies in hematological malignancies

CD47 is a cell-surface ligand that is overexpressed in various malignancies and that binds to SIRPα on macrophages to promote tumor cell evasion of phagocytosis. Blocking the CD47-SIRPα axis can increase the phagocytosis of macrophages to exert antitumor effects. CD47-based immunotherapy is a curren...

Full description

Bibliographic Details
Main Authors: Yilan Xu, Panruo Jiang, Zhenyan Xu, Haige Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1348852/full